Molecular mechanisms of immune privilege of the cornea – as a potential of Immune checkpoint therapy

E-ISSN： 1755-3768|94|S256|j.1755-3768.2016.0231-j.1755-3768.2016.0231

ISSN： 1755-375X

Source： ACTA OPHTHALMOLOGICA, Vol.94, Iss.S256, 2016-10, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 10, 2015-10 ,pp. : 963-976

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immune checkpoint inhibition in lymphoid disease

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 3, 2015-08 ,pp. : 291-304

John Wiley & Sons Inc

Access to resources Recommend Favorite

Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery

CANCER, Vol. 122, Iss. 19, 2016-10 ,pp. : 3051-3058

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Cornea Has “the Nerve” to Encourage Immune Rejection

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 6, 2015-06 ,pp. : 1453-1454

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immune checkpoint inhibitors: new strategies to checkmate cancer

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 191, Iss. 2, 2018-02 ,pp. : 133-148

John Wiley & Sons Inc

Access to resources Recommend Favorite